On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd.

54 YRS

Jiangsu, China

CNY 180 Million

43290 m²

100-500 people

Main Products: Gemcitabine Hydrochloride / Tofacitinib Citrate / Celecoxib / Gefitinib / Iguratimod / Azilsartan / Cinacalcet Hydrochloride / Apremilast / Allicin

Jiangsu, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

Apremilast / CAS 608141-41-9

OVERVIEW

Packaging

25 KG/Fibre Drum

Lead Time

14-30 days

REQUEST A QUOTATION

Submit

Get Free Samples

Less than 1KG required

DESCRIPTION

Apremilast

Product introduction:

Apremilast is an oral selective phosphodiesterase 4 (PDE4) inhibitor developed by celgene company of the United States. The trade name is otezla. It is the first and only PDE4 inhibitor approved by FDA for the treatment of plaque psoriasis. It is used for the treatment of adult patients with moderate to severe plaque psoriasis suitable for phototherapy and systemic therapy.

CAS：608141-41-9

Molecular formula: C₂₂H₂₄N₂O₇S

Molecular weight: 460.5

Structural type:

Product purpose:

It is suitable for adult patients with active psoriatic arthritis.

Typical Properties

Apremilast is an oral phosphodiesterase 4 inhibitor is used in the treatment of psoriatic arthritis.

CAS No.

608141-41-9

Formula

C22H24N2O7S

Molecular Mass

460.5

Exact Mass

460.13000

PSA

127.46000

Logp

3.52590

IUPAC

N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide

SMILES

CCOC1=C(C=CC(=C1)[C@@H](CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC

GET SAMPLE